Table 6.
Correlation analysis between serum antibody marker levels and sex, other diseases, lifestyle, and obesity
| ALDOA-Ab | FH-Ab | ||||
|---|---|---|---|---|---|
| Sex | Male | Female | Male | Female | |
| Sample number | 692 | 458 | 692 | 458 | |
| Antibody level | Average | 19,087 | 18,196 | 3,323 | 3,492 |
| SD | 11,046 | 10,456 | 3,258 | 3,630 | |
| P value (vs Male) | 0.1941 | 0.2563 | |||
| DM | DM (–) | DM ( +) | DM (–) | DM ( +) | |
| Sample number | 926 | 219 | 926 | 219 | |
| Antibody level | Average | 18,637 | 19,189 | 3,315 | 3,710 |
| SD | 11,045 | 9,902 | 3,425 | 3,349 | |
| P value [vs DM (–)] | 0.1250 | 0.0183 | |||
| Blood pressure | HT (–) | HT ( +) | HT (–) | HT ( +) | |
| Sample number | 505 | 640 | 505 | 640 | |
| Antibody level | Average | 17,927 | 19,388 | 2,977 | 3,717 |
| SD | 11,037 | 10,635 | 2,985 | 3,685 | |
| P value [vs HT (–)] | 0.0022 | < 0.0001 | |||
| CHD | CHD (–) | CHD ( +) | CHD– | CHD + | |
| Sample number | 1086 | 59 | 1086 | 59 | |
| Antibody level | Average | 18,600 | 21,373 | 3,336 | 4,397 |
| SD | 10,685 | 13,087 | 3,351 | 4,302 | |
| P value [vs CHD (–)] | 0.0400 | 0.0268 | |||
| Lipidemia | HL (–) | HL ( +) | HL (–) | HL ( +) | |
| Sample number | 844 | 301 | 844 | 301 | |
| Antibody level | Average | 18,871 | 18,384 | 3,514 | 3,045 |
| SD | 11,144 | 9,923 | 3,688 | 2,455 | |
| P value [vs HL (–)] | 0.6244 | 0.6545 | |||
| Life style | Non-smoker | Smoker | Non-smoker | Smoker | |
| Sample number | 584 | 561 | 584 | 561 | |
| Antibody level | Average | 17,371 | 20,158 | 3,282 | 3,494 |
| SD | 9,641 | 11,783 | 3,587 | 3,186 | |
| P value (vs non-smoker) | < 0.0001 | 0.0566 | |||
| Life style | Alcohol (–) | Alcohol ( +) | Alcohol (–) | Alcohol ( +) | |
| Sample number | 338 | 570 | 338 | 570 | |
| Antibody level | Average | 17,928 | 19,507 | 3,528 | 3,466 |
| SD | 9,311 | 12,373 | 3,544 | 3,492 | |
| P value [vs Alcohol (-)] | 0.0817 | 0.8972 | |||
| Obesity | BMI < 25 | BMI ≥ 25 | BMI < 25 | BMI ≥ 25 | |
| Sample number | 809 | 315 | 809 | 315 | |
| Antibody level | Average | 18,911 | 18,568 | 3,577 | 2,992 |
| SD | 11,198 | 10,049 | 3,722 | 2,475 | |
| P value (vs BMI < 25) | 0.8354 | 0.0720 | |||
The subjects were divided into two groups as follows: sex (male and female); presence ( +) or absence ( −) of complication of DM, HT, CHD or hyperlipidemia (HL), lifestyle factors (smoking and alcohol intake habits), and obesity. Antibody levels (alpha counts) were compared using the Mann–Whitney U test. Sample numbers, averages and SDs of counts as well as P values are shown. Significant correlations (P < 0.05) are marked in bold